JTC Employer Solutions Trustee’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

JTC Employer Solutions Trustee’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65K	Buy	1,920 +960	+100%	+$32K	0.01%	233
2026 Q1	$29K	Sell	960 -2,240	-70%	-$72.1K	﹤0.01%	259
2025 Q4	$100K	Hold	3,200	–	–	0.01%	211
2025 Q3	$65K	Buy	+3,200	New	+$56.2K	0.01%	229
2023 Q4	–	Sell	-800	Closed	-$8K	–	361
2023 Q3	$8K	Hold	800	–	–	﹤0.01%	320
2023 Q2	$6K	Hold	800	–	–	﹤0.01%	337
2023 Q1	$7K	Hold	800	–	–	﹤0.01%	343
2022 Q4	$7K	Hold	800	–	–	﹤0.01%	362
2022 Q3	$6K	Hold	800	–	–	﹤0.01%	300
2022 Q2	$6K	Hold	800	–	–	﹤0.01%	276
2022 Q1	$8K	Hold	800	–	–	﹤0.01%	284
2021 Q4	$6K	Hold	800	–	–	﹤0.01%	291
2021 Q3	$8K	Hold	800	–	–	﹤0.01%	286
2021 Q2	$8K	Buy	+800	New	+$8.47K	﹤0.01%	279

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

JTC Employer Solutions Trustee's TEVA Position: Q2 2026 in Review

JTC Employer Solutions Trustee increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 100% in Q2 2026, buying an estimated $32K and bringing the position to 1,920 shares worth $65K. The position accounts for 0.01% of the portfolio, ranked #233.

JTC Employer Solutions Trustee first reported a position in TEVA in Q2 2021 and has held it in 14 quarters since. The position peaked at $100K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

JTC Employer Solutions Trustee held 1,920 shares of Teva Pharmaceutical Industries Limited worth $65K as of Q2 2026.
JTC Employer Solutions Trustee bought 960 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $32K.
Teva Pharmaceutical Industries Limited made up 0.01% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #233 holding.
JTC Employer Solutions Trustee first reported a position in Teva Pharmaceutical Industries Limited in Q2 2021 and has held it in 14 quarters since.
JTC Employer Solutions Trustee's Teva Pharmaceutical Industries Limited position peaked at $100K in Q4 2025.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.